Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCRN
1676
DELISTED
Milacron Holdings Corp.
MCRN
| $2.86M | 0.01% |
162,712
-420,486
| -72% | -$7.97M |
|
1677
Installed Building Products
IBP
$6.56B
| $2.85M | 0.01% |
+112,850
| New | +$3.05M |
|
|
DRNA
1678
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.85M | 0.01% |
347,044
-43,420
| -11% | -$501K |
|
1679
PUT
Louisiana-Pacific
LPX
$5.06B
| $2.85M | 0.01% |
+200,000
| New | +$3.17M |
|
1680
Globus Medical
GMED
$11.1B
| $2.85M | 0.01% |
137,698
+84,495
| +159% | +$2.14M |
|
|
XOXO
1681
DELISTED
Xo Group Inc
XOXO
| $2.85M | 0.01% |
201,341
+78,577
| +64% | +$1.18M |
|
|
PNNT
1682
Pennant Park Investment Corp
PNNT
$249M
| $2.84M | 0.01% |
438,783
+162,479
| +59% | +$1.25M |
|
|
MLNX
1683
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $2.84M | 0.01% |
75,053
-245,671
| -77% | -$10.5M |
|
|
BHR
1684
Braemar Hotels & Resorts
BHR
$141M
| $2.83M | 0.01% |
204,005
+145,351
| +248% | +$2.07M |
|
1685
Goldman Sachs
GS
$308B
| $2.83M | 0.01% |
+16,269
| New | +$3.19M |
|
1686
Barnes & Noble Education
BNED
$437M
| $2.82M | 0.01% |
+2,220
| New | +$2.87M |
|
|
NAVG
1687
DELISTED
Navigators Group Inc
NAVG
| $2.82M | 0.01% |
72,272
+16,044
| +29% | +$623K |
|
1688
Herbalife
HLF
$1.35B
| $2.81M | 0.01% |
103,128
-51,734
| -33% | -$1.42M |
|
|
AUY
1689
DELISTED
Yamana Gold, Inc.
AUY
| $2.81M | 0.01% |
1,649,727
-293,575
| -15% | -$600K |
|
1690
AGNC Investment
AGNC
$12.9B
| $2.8M | 0.01% |
149,960
+97,166
| +184% | +$1.87M |
|
|
AD
1691
Array Digital Infrastructure
AD
$3.1B
| $2.8M | 0.01% |
79,152
-4,821
| -6% | -$177K |
|
|
RPRX
1692
DELISTED
Repros Therapeutics Inc.
RPRX
| $2.8M | 0.01% |
377,064
-393,612
| -51% | -$3.01M |
|
1693
Chesapeake Utilities
CPK
$3.25B
| $2.8M | 0.01% |
+52,674
| New | +$2.68M |
|
|
BOJA
1694
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $2.78M | 0.01% |
164,718
+150,546
| +1,062% | +$3.25M |
|
1695
Douglas Dynamics
PLOW
$962M
| $2.78M | 0.01% |
140,114
+80,407
| +135% | +$1.71M |
|
1696
Alto Ingredients
ALTO
$309M
| $2.78M | 0.01% |
428,427
+39,655
| +10% | +$303K |
|
|
PDLI
1697
DELISTED
PDL BioPharma, Inc.
PDLI
| $2.78M | 0.01% |
552,576
-344,039
| -38% | -$1.97M |
|
1698
Vanguard Total International Bond ETF
BNDX
$83B
| $2.78M | 0.01% |
+52,447
| New | +$2.77M |
|
1699
Werner Enterprises
WERN
$2.26B
| $2.77M | 0.01% |
+110,500
| New | +$3.02M |
|
|
GWPH
1700
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.77M | 0.01% |
30,316
+7,236
| +31% | +$805K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.